The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.

@article{Taner2013TheVO,
  title={The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.},
  author={Alpaslan Taner and Ali Unlu and Mehmet Kayrak and Mehmet Tekinalp and Selim Suzi Ayhan and Alpay Arıbaş and Said Sami Erdem},
  journal={Atherosclerosis},
  year={2013},
  volume={228 2},
  pages={432-7}
}
BACKGROUND An increased prevalence of masked hypertension (MHT) has been demonstrated among patients with diabetes mellitus (DM). MHT appears to cause cardiovascular (CV) complications similar to clinically overt hypertension. Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide inhibitor and higher plasma levels of ADMA are related to increased CV risk in both the general population and among patients with DM. The aim of this study was to evaluate the relationship between MHT and… CONTINUE READING
3 Citations
39 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Similar Papers

Loading similar papers…